期刊论文详细信息
Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders | |
Risedronate's Role in Reducing Hip Fracture in Postmenopausal Women with Established Osteoporosis | |
Expert Review | |
Shyamal Das1  Brian J. Gates2  | |
[1] US Field Medical, Novartis Pharmaceuticals Corp, East Hanover, NJ.;Washington State University College of Pharmacy, PO Box 1495, Spokane WA.; | |
关键词: risedronate; hip fracture; osteoporosis; bisphosphonate; postmenopausal women; | |
DOI : 10.4137/CMAMD.S4092 | |
来源: Sage Journals | |
【 授权许可】
CC BY-NC
© 2012 SAGE Publications.
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO202212200410780ZK.pdf | 536KB | download | |
Table 1 | 285KB | Table | download |
【 参考文献 】
- [1]
- [2]
- [3]
- [4]
- [5]
- [6]
- [7]
- [8]
- [9]
- [10]
- [11]
- [12]
- [13]
- [14]
- [15]
- [16]
- [17]
- [18]
- [19]
- [20]
- [21]
- [22]
- [23]
- [24]
- [25]
- [26]
- [27]
- [28]
- [29]
- [30]
- [31]
- [32]
- [33]
- [34]
- [35]
- [36]
- [37]
- [38]
- [39]
- [40]
- [41]
- [42]
- [43]
- [44]
- [45]
- [46]
- [47]
- [48]
- [49]
- [50]
- [51]
- [52]
- [53]
- [54]
- [55]
- [56]
- [57]
- [58]
- [59]
- [60]
- [61]
- [62]
- [63]
- [64]
- [65]
- [66]
- [67]
- [68]